A Duke University study reveals that pancreatic alpha cells, long known for producing glucagon, also naturally release GLP-1, the hormone behind drugs like Ozempic. When glucagon production is blocked, alpha cells increase GLP-1 output, enhancing insulin release and blood sugar control. This discovery could lead to new diabetes treatments harnessing the body's own hormone regulation.